Increased levels of NOTCH1, NF-B, and other interconnected transcription factors characterize primitive sets of hematopoietic stem cells

Stem Cells and Development

Volumn 19, Issue 3, 2010, Pages 321-332

  Panepucci, Rodrigo Alexandre ^a   Oliveira, Lucila Habib B ^a   Zanette, Dalila Luciola ^a   Viu Carrara, Rita De Cassia ^a   Araujo, Amélia Goes ^a   Orellana, Maristela Delgado ^a   Bonini De Palma, Patrícia Vianna ^a   Menezes, Camila C B O ^a   Covas, Dimas Tadeu ^a   Zago, Marco Antonio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NOTCH1 RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR HOXA9; TRANSCRIPTION FACTOR HOXB4; TRANSCRIPTION FACTOR RELB; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR TAL1; UNCLASSIFIED DRUG; UPSTREAM STIMULATORY FACTOR 1;

ARTICLE; BINDING SITE; BONE MARROW; CELL RENEWAL; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UMBILICAL CORD BLOOD; UNINDEXED SEQUENCE;

ANTIGENS, CD; ANTIGENS, CD34; CELL LINEAGE; CLUSTER ANALYSIS; FETAL BLOOD; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GLYCOPROTEINS; HEMATOPOIETIC STEM CELLS; HUMANS; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEPTIDES; RECEPTOR, NOTCH1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELLS; TRANSCRIPTION FACTORS;

EID: 77949631210     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2008.0397     Document Type: Article

References (91)

1. Frassoni F, M Podesta, R Maccario, G Giorgiani, G Rossi, M Zecca, A Bacigalupo, G Piaggio and F Locatelli. (2003). Cord blood transplantation provides better reconstitution of hematopoietic reservoir compared with bone marrow transplantation. Blood 102:1138-1141.
2. Talvensaari K, E Clave, C Douay, C Rabian, L Garderet, M Busson, F Garnier, D Douek, E Gluckman, D Charron and A Toubert. (2002). A broad T-cell repertoire diversity and an effi cient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation. Blood 99:1458-1464.
3. Noort WA, J Wilpshaar, CD Hertogh, M Rad, EG Lurvink, SA van Luxemburg-Heijs, K Zwinderman, RA Verwey, R Willemze and JH Falkenburg. (2001). Similar myeloid recovery despite superior overall engraftment in NOD/SCID mice after transplantation of human CD34(+) cells from umbilical cord blood as compared to adult sources. Bone Marrow Transplant 28:163-171.
4. Theunissen K and CM Verfaillie. (2005). A multifactorial analysis of umbilical cord blood, adult bone marrow and mobilized peripheral blood progenitors using the improved ML-IC assay. Exp Hematol 33:165-172.
5. Voermans C, WR Gerritsen, AE von dem Borne and CE van der Schoot. (1999). Increased migration of cord blood-derived CD34+ cells, as compared to bone marrow and mobilized peripheral blood CD34+ cells across uncoated or fi bronectincoated fi lters. Exp Hematol 27:1806-1814.
6. Yeoman H, RE Gress, CV Bare, AG Leary, EA Boyse, J Bard, LD Shultz, DT Harris and D DeLuca. (1993). Human bone marrow and umbilical cord blood cells generate CD4+ and CD8+ single- positive T cells in murine fetal thymus organ culture. Proc Natl Acad Sci USA 90:10778-10782.
7. Panepucci RA, RT Calado, V Rocha, R Proto-Siqueira, WA SilvaJr and MA Zago. (2007). Higher expression of transcription targets and components of the nuclear factor-kappaB pathway is a distinctive feature of umbilical cord blood CD34+ precursors. Stem Cells 25:189-196.
8. Cheng P, A Zlobin, V Volgina, S Gottipati, B Osborne, EJ Simel, L Miele and DI Gabrilovich. (2001). Notch-1 regulates NF-kappaB activity in hemopoietic progenitor cells. J Immunol 167:4458-4467.
9. Shin HM, LM Minter, OH Cho, S Gottipati, AH Fauq, TE Golde, GE Sonenshein and BA Osborne. (2006). Notch1 augments NF-kappaB activity by facilitating its nuclear retention. EMBO J 25:129-138.
10. Burt RK. (1999). Clinical utility in maximizing CD34+ cell count in stem cell grafts. Stem Cells 17:373-376.
11. de Wynter EA, D Buck, C Hart, R Heywood, LH Coutinho, A Clayton, JA Rafferty, D Burt, G Guenechea, JA Bueren, D Gagen, LJ Fairbairn, BI Lord and NG Testa. (1998). CD34+AC133+ cells isolated from cord blood are highly enriched in long-term culture- initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors. Stem Cells 16:387-396.
12. Gehling UM. (2006). Hemangioblasts and their progeny. Meth Enzymol 419:179-193.
13. Bailey AS, S Jiang, M Afentoulis, CI Baumann, DA Schroeder, SB Olson, MH Wong and WH Fleming. (2004). Transplanted adult hematopoietic stems cells differentiate into functional endothelial cells. Blood 103:13-19.
14. Rizzatti EG, RP Falcao, RA Panepucci, R Proto-Siqueira, WT Anselmo-Lima, OK Okamoto and MA Zago. (2005). Gene expression profi ling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K-AKT, WNT and TGFbeta signalling pathways. Br J Haematol 130:516-526.
15. de Hoon MJ, S Imoto, J Nolan and S Miyano. (2004). Open source clustering software. Bioinformatics 20:1453-1454.
16. Eisen MB, PT Spellman, PO Brown and D Botstein. (1998). Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95:14863-14868.
17. Tusher VG, R Tibshirani and G Chu. (2001). Signifi cance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98:5116-5121.
18. Cole SW, W Yan, Z Galic, J Arevalo and JA Zack. (2005). Expression-based monitoring of transcription factor activity: the TELiS database. Bioinformatics 21:803-810.
19. Wingender E, X Chen, E Fricke, R Geffers, R Hehl, I Liebich, M Krull, V Matys, H Michael, R Ohnhauser, M Pruss, F Schacherer, S Thiele and S Urbach. (2001). The TRANSFAC system on gene expression regulation. Nucleic Acids Res 29:281-283.
20. van HJ. (2003). Regulatory sequence analysis tools. Nucleic Acids Res 31:3593-3596.
21. Thomas-Chollier M, O Sand, JV Turatsinze, R Janky, M Defrance, E Vervisch, S Brohee and J van Helden. (2008). RSAT: regulatory sequence analysis tools. Nucleic Acids Res 36(Web Server issue):W119-W127.
22. Ong CT, HT Cheng, LW Chang, T Ohtsuka, R Kageyama, GD Stormo and R Kopan. (2006). Target selectivity of vertebrate notch proteins. Collaboration between discrete domains and CSL-binding site architecture determines activation probability. J Biol Chem 281:5106-5119.
23. Halees AS, D Leyfer and Z Weng. (2003). PromoSer: a large-scale mammalian promoter and transcription start site identifi cation service. Nucleic Acids Res 31:3554-3559.
24. Asnagli H, M Afkarian and KM Murphy. (2002). Cutting edge: identifi cation of an alternative GATA-3 promoter directing tissue- specifi c gene expression in mouse and human. J Immunol 168:4268-4271.
25. Kent WJ, CW Sugnet, TS Furey, KM Roskin, TH Pringle, AM Zahler and D Haussler. (2002). The human genome browser at UCSC. Genome Res 12:996-1006.
26. Pfaffl MW. (2001). A new mathematical model for relative quantifi cation in real-time RT-PCR. Nucleic Acids Res 29:e45.
27. Weekx SF, DR Van Bockstaele, J Plum, A Moulijn, I Rodrigus, F Lardon, M De Smedt, G Nijs, M Lenjou, P Loquet, ZN Berneman and HW Snoeck. (1998). CD34++ CD38- and CD34+ CD38+ human hematopoietic progenitors from fetal liver, cord blood, and adult bone marrow respond differently to hematopoietic cytokines depending on the ontogenic source. Exp Hematol 26:1034-1042.
28. Shojaei F, L Gallacher and M Bhatia. (2004). Differential gene expression of human stem progenitor cells derived from early stages of in utero human hematopoiesis. Blood 103:2530-2540.
29. Yin AH, S Miraglia, ED Zanjani, G Almeida-Porada, M Ogawa, AG Leary, J Olweus, J Kearney and DW Buck. (1997). AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90:5002-5012.
30. He X, V Gonzalez, A Tsang, J Thompson, TC Tsang and DT Harris. (2005). Differential gene expression profi ling of CD34+ CD133+ umbilical cord blood hematopoietic stem progenitor cells. Stem Cells Dev 14:188-198.
31. Okamoto OK, AC Carvalho, LC Marti, RZ Vencio and CA Moreira-Filho. (2007). Common molecular pathways involved in human CD133+/CD34+ progenitor cell expansion and cancer. Cancer Cell Int 7:11.
32. Pomyje J, J Zivny, L Sefc, M Plasilova, R Pytlik and E Necas. (2003). Expression of genes regulating angiogenesis in human circulating hematopoietic cord blood CD34+/CD133+ cells. Eur J Haematol 70:143-150.
33. Ng YY, B van Kessel, HM Lokhorst, MR Baert, CM van den Burg, AC Bloem and FJ Staal. (2004). Gene-expression profi ling of CD34+ cells from various hematopoietic stem-cell sources reveals functional differences in stem-cell activity. J Leukoc Biol 75:314-323.
34. Sandberg ML, SE Sutton, MT Pletcher, T Wiltshire, LM Tarantino, JB Hogenesch and MP Cooke. (2005). c-Myb and p300 regulate hematopoietic stem cell proliferation and differentiation. Dev Cell 8:153-166.
35. Blobel GA. (2002). CBP and p300: versatile coregulators with important roles in hematopoietic gene expression. J Leukoc Biol 71:545-556.
36. Greig KT, S Carotta and SL Nutt. (2008). Critical roles for c-Myb in hematopoietic progenitor cells. Semin Immunol 20:247-256.
37. Hirai H, IM Samokhvalov, T Fujimoto, S Nishikawa, J Imanishi and S Nishikawa. (2005). Involvement of Runx1 in the downregulation of fetal liver kinase-1 expression during transition of endothelial cells to hematopoietic cells. Blood 106:1948-1955.
38. Tsuzuki S, D Hong, R Gupta, K Matsuo, M Seto and T Enver. (2007). Isoform-specifi c potentiation of stem and progenitor cell engraftment by AML1/RUNX1. PLoS Med 4:e172.
39. Ho IC and SY Pai. (2007). GATA-3-not just for Th2 cells anymore. Cell Mol Immunol 4:15-29.
40. Giannola DM, WD Shlomchik, M Jegathesan, D Liebowitz, CS Abrams, T Kadesch, A Dancis and SG Emerson. (2000). Hematopoietic expression of HOXB4 is regulated in normal and leukemic stem cells through transcriptional activation of the HOXB4 promoter by upstream stimulating factor (USF)-1 and USF-2. J Exp Med 192:1479-1490.
41. Zhu J, DM Giannola, Y Zhang, AJ Rivera and SG Emerson. (2003). NF-Y cooperates with USF1/2 to induce the hematopoietic expression of HOXB4. Blood 102:2420-2427.
42. Jaffredo T, K Bollerot, D Sugiyama, R Gautier and C Drevon. (2005). Tracing the hemangioblast during embryogenesis: developmental relationships between endothelial and hematopoietic cells. Int J Dev Biol 49:269-277.
43. Kurita R, E Sasaki, T Yokoo, T Hiroyama, K Takasugi, H Imoto, K Izawa, Y Dong, T Hashiguchi, Y Soda, T Maeda, Y Suehiro, Y Tanioka, Y Nakazaki and K Tani. (2006). Tal1/Scl gene transduction using a lentiviral vector stimulates highly effi cient hematopoietic cell differentiation from common marmoset (Callithrix jacchus) embryonic stem cells. Stem Cells 24:2014-2022.
44. Patterson LJ, M Gering, CE Eckfeldt, AR Green, CM Verfaillie, SC Ekker and R Patient. (2007). The transcription factors Scl and Lmo2 act together during development of the hemangioblast in zebrafi sh. Blood 109:2389-2398.
45. Reynaud D, E Ravet, M Titeux, F Mazurier, L Renia, A Dubart- Kupperschmitt, PH Romeo and F Pfl umio. (2005). SCL/TAL1 expression level regulates human hematopoietic stem cell selfrenewal and engraftment. Blood 106:2318-2328.
46. Dorsam ST, CM Ferrell, GP Dorsam, MK Derynck, U Vijapurkar, D Khodabakhsh, B Pau, H Bernstein, CM Haqq, C Largman and HJ Lawrence. (2004). The transcriptome of the leukemogenic homeoprotein HOXA9 in human hematopoietic cells. Blood 103:1676-1684.
47. Ferrell CM, ST Dorsam, H Ohta, RK Humphries, MK Derynck, C Haqq, C Largman and HJ Lawrence. (2005). Activation of stemcell specifi c genes by HOXA9 and HOXA10 homeodomain proteins in CD34+ human cord blood cells. Stem Cells 23:644-655.
48. Wagner W, A Ansorge, U Wirkner, V Eckstein, C Schwager, J Blake, K Miesala, J Selig, R Saffrich, W Ansorge and AD Ho. (2004). Molecular evidence for stem cell function of the slowdividing fraction among human hematopoietic progenitor cells by genome-wide analysis. Blood 104:675-686.
49. Buske C, M Feuring-Buske, C Abramovich, K Spiekermann, CJ Eaves, L Coulombel, G Sauvageau, DE Hogge and RK Humphries. (2002). Deregulated expression of HOXB4 enhances the primitive growth activity of human hematopoietic cells. Blood 100:862-868.
50. Struhl K. (1998). Histone acetylation and transcriptional regulatory mechanisms. Genes Dev 12:599-606.
51. Chen H, M Tini and RM Evans. (2001). HATs on and beyond chromatin. Curr Opin Cell Biol 13:218-224.
52. Tomita A, M Towatari, S Tsuzuki, F Hayakawa, H Kosugi, K Tamai, T Miyazaki, T Kinoshita and H Saito. (2000). c-Myb acetylation at the carboxyl-terminal conserved domain by transcriptional co-activator p300. Oncogene 19:444-451.
53. Chen LF and WC Greene. (2003). Regulation of distinct biological activities of the NF-kappaB transcription factor complex by acetylation. J Mol Med 81:549-557.
54. Yamagata T, K Mitani, H Oda, T Suzuki, H Honda, T Asai, K Maki, T Nakamoto and H Hirai. (2000). Acetylation of GATA-3 affects T-cell survival and homing to secondary lymphoid organs. EMBO J 19:4676-4687.
55. Huang S, Y Qiu, RW Stein and SJ Brandt. (1999). p300 functions as a transcriptional coactivator for the TAL1/SCL oncoprotein. Oncogene 18:4958-4967.
56. Huang S, Y Qiu, Y Shi, Z Xu and SJ Brandt. (2000). P/CAFmediated acetylation regulates the function of the basic helix-loop-helix transcription factor TAL1/SCL. EMBO J 19:6792-6803.
57. Yamaguchi Y, M Kurokawa, Y Imai, K Izutsu, T Asai, M Ichikawa, G Yamamoto, E Nitta, T Yamagata, K Sasaki, K Mitani, S Ogawa, S Chiba and H Hirai. (2004). AML1 is functionally regulated through p300-mediated acetylation on specifi c lysine residues. J Biol Chem 279:15630-15638.
58. Oswald F, B Tauber, T Dobner, S Bourteele, U Kostezka, G Adler, S Liptay and RM Schmid. (2001). p300 acts as a transcriptional coactivator for mammalian Notch-1. Mol Cell Biol 21:7761-7774.
59. Toth CR, RF Hostutler, AS Baldwin Jr. and TP Bender. (1995). Members of the nuclear factor kappa B family transactivate the murine c-myb gene. J Biol Chem 270:7661-7671.
60. Amsen D, A Antov, D Jankovic, A Sher, F Radtke, A Souabni, M Busslinger, B McCright, T Gridley and RA Flavell. (2007). Direct regulation of Gata3 expression determines the T helper differentiation potential of Notch. Immunity 27:89-99.
61. Fang TC, Y Yashiro-Ohtani, C Del Bianco, DM Knoblock, SC Blacklow and WS Pear. (2007). Notch directly regulates Gata3 expression during T helper 2 cell differentiation. Immunity 27:100-110.
62. Kubo M. (2007). Notch: fi lling a hole in T helper 2 cell differentiation. Immunity 27:3-5.
63. Burns CE, D Traver, E Mayhall, JL Shepard and LI Zon. (2005). Hematopoietic stem cell fate is established by the Notch-Runx pathway. Genes Dev 19:2331-2342.
64. Kumano K, S Chiba, A Kunisato, M Sata, T Saito, E Nakagami-Yamaguchi, T Yamaguchi, S Masuda, K Shimizu, T Takahashi, S Ogawa, Y Hamada and H Hirai. (2003). Notch1 but not Notch2 is essential for generating hematopoietic stem cells from endothelial cells. Immunity 18:699-711.
65. Hsu HL, L Huang, JT Tsan, W Funk, WE Wright, JS Hu, RE Kingston and R Baer. (1994). Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins. Mol Cell Biol 14:1256-1265.
66. Gothert JR, RL Brake, M Smeets, U Duhrsen, CG Begley and DJ Izon. (2007). NOTCH1 pathway activation is an early hallmark of SCL T leukemogenesis. Blood 110:3753-3762.
67. Mikkola HK, J Klintman, H Yang, H Hock, TM Schlaeger, Y Fujiwara and SH Orkin. (2003). Haematopoietic stem cells retain long-term repopulating activity and multipotency in the absence of stem-cell leukaemia SCL/tal-1 gene. Nature 421:547-551.
68. Ikawa T, H Kawamoto, AW Goldrath and C Murre. (2006). E proteins and Notch signaling cooperate to promote T cell lineage specifi cation and commitment. J Exp Med 203:1329-1342.
69. Yang Q, L Kardava, A St Leger, K Martincic, B Varnum-Finney, ID Bernstein, C Milcarek and L Borghesi. (2008). E47 controls the developmental integrity and cell cycle quiescence of multipotential hematopoietic progenitors. J Immunol 181:5885-5894.
70. Ordentlich P, A Lin, CP Shen, C Blaumueller, K Matsuno, S Artavanis-Tsakonas and T Kadesch. (1998). Notch inhibition of E47 supports the existence of a novel signaling pathway. Mol Cell Biol 18:2230-2239.
71. Nie L, H Wu and XH Sun. (2008). Ubiquitination and degradation of Tal1/SCL are induced by notch signaling and depend on Skp2 and CHIP. J Biol Chem 283:684-692.
72. Goardon N, A Schuh, I Hajar, X Ma, H Jouault, E Dzierzak, PH Romeo and L Maouche-Chretien. (2002). Ectopic expression of TAL-1 protein in Ly-6E.1-htal-1 transgenic mice induces defects in B- and T-lymphoid differentiation. Blood 100:491-500.
73. Miyoshi H, M Ohira, K Shimizu, K Mitani, H Hirai, T Imai, K Yokoyama, E Soeda and M Ohki. (1995). Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia. Nucleic Acids Res 23:2762-2769.
74. Aplan PD, CG Begley, V Bertness, M Nussmeier, A Ezquerra, J Coligan and IR Kirsch. (1990). The SCL gene is formed from a transcriptionally complex locus. Mol Cell Biol 10:6426-6435.
75. Landry JR, S Kinston, K Knezevic, MF de Bruijn, N Wilson, WT Nottingham, M Peitz, F Edenhofer, JE Pimanda, K Ottersbach and B Gottgens. (2008). Runx genes are direct targets of Scl/Tal1 in the yolk sac and fetal liver. Blood 111:3005-3014.
76. Nottingham WT, A Jarratt, M Burgess, CL Speck, JF Cheng, S Prabhakar, EM Rubin, PS Li, J Sloane-Stanley, J Kong-A-San and MF de Bruijn. (2007). Runx1-mediated hematopoietic stem-cell emergence is controlled by a Gata/Ets/SCL-regulated enhancer. Blood 110:4188-4197.
77. Ramdass B, TT Maliekal, S Lakshmi, M Rehman, P Rema, P Nair, G Mukherjee, BK Reddy, S Krishna and M Radhakrishna Pillai. (2007). Coexpression of Notch1 and NF-kappaB signaling pathway components in human cervical cancer progression. Gynecol Oncol 104:352-361.
78. Wang Z, S Banerjee, Y Li, KM Rahman, Y Zhang and FH Sarkar. (2006). Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells. Cancer Res 66:2778-2784.
79. Wang Z, Y Zhang, S Banerjee, Y Li and FH Sarkar. (2006). Inhibition of nuclear factor kappab activity by genistein is mediated via Notch-1 signaling pathway in pancreatic cancer cells. Int J Cancer 118:1930-1936.
80. Chen Y, W Shu, W Chen, Q Wu, H Liu and G Cui. (2007). Curcumin, both histone deacetylase and p300/CBP-specifi c inhibitor, represses the activity of nuclear factor kappa B and Notch 1 in Raji cells. Basic Clin Pharmacol Toxicol 101:427-433.
81. Nakazawa M, H Ishii, H Nakamura, SI Yoshino, A Fukamizu, K Nishioka and T Nakajima. (2001). NFkappaB2 (p52) promoter activation via Notch signaling pathway in rheumatoid synoviocytes. Int J Mol Med 7:31-35.
82. Oswald F, S Liptay, G Adler and RM Schmid. (1998). NF-kappaB2 is a putative target gene of activated Notch-1 via RBP-Jkappa. Mol Cell Biol 18:2077-2088.
83. Borggrefe T and F Oswald. (2009). The Notch signaling pathway: transcriptional regulation at Notch target genes. Cell Mol Life Sci 66:1631-1646.
84. Chiba S. (2006). Notch signaling in stem cell systems. Stem Cells 24:2437-2447.
85. Maillard I, U Koch, A Dumortier, O Shestova, L Xu, H Sai, SE Pross, JC Aster, A Bhandoola, F Radtke and WS Pear. (2008). Canonical notch signaling is dispensable for the maintenance of adult hematopoietic stem cells. Cell Stem Cell 2:356-366.
86. Perumalsamy LR, M Nagala, P Banerjee and A Sarin. (2009). A hierarchical cascade activated by non-canonical Notch signaling and the mTOR-Rictor complex regulates neglect-induced death in mammalian cells. Cell Death Differ 16:879-889.
87. Talora C, AF Campese, D Bellavia, MP Felli, A Vacca, A Gulino and I Screpanti. (2008). Notch signaling and diseases: an evolutionary journey from a simple beginning to complex outcomes. Biochim Biophys Acta 1782:489-497.
88. Maillard I, T Fang and WS Pear. (2005). Regulation of lymphoid development, differentiation, and function by the Notch pathway. Annu Rev Immunol 23:945-974.
89. Maillard I, BA Schwarz, A Sambandam, T Fang, O Shestova, L Xu, A Bhandoola and WS Pear. (2006). Notch-dependent T-lineage commitment occurs at extrathymic sites following bone marrow transplantation. Blood 107:3511-3519.
90. Aguilera C, R Hoya-Arias, G Haegeman, L Espinosa and A Bigas. (2004). Recruitment of IkappaBalpha to the hes1 promoter is associated with transcriptional repression. Proc Natl Acad Sci USA 101:16537-16542.
91. Boyer LA, TI Lee, MF Cole, SE Johnstone, SS Levine, JP Zucker, MG Guenther, RM Kumar, HL Murray, RG Jenner, DK Gifford, DA Melton, R Jaenisch and RA Young. (2005). Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122:947-956.